Related references
Note: Only part of the references are listed.Long-term outcome in BRAFV600E melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression
Igor Puzanov et al.
EUROPEAN JOURNAL OF CANCER (2015)
Human relevance of NRAS/BRAF mouse melanoma models
Alejandro Conde-Perez et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2014)
Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker
Johanne Lade-Keller et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
An objective measure of growth rate using partial biopsy specimens of melanomas that were initially misdiagnosed
Matthew J. Lin et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma
Georgina V. Long et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
NRAS and BRAF Mutations in Melanoma-Associated Nevi and Uninvolved Nevi
Philipp Tschandl et al.
PLOS ONE (2013)
Variegated Dermoscopy of in situ Melanoma
Stefania Seidenari et al.
DERMATOLOGY (2012)
Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma
Ashley Mason et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2012)
Absence of Distinguishing Senescence Traits in Human Melanocytic Nevi
Sieu L. Tran et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
David Capper et al.
ACTA NEUROPATHOLOGICA (2011)
The Dermoscopical and Histopathological Patterns of Nevi Correlate with the Frequency of BRAF Mutations
Iris Zalaudek et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
p16 Expression: A marker of differentiation between childhood malignant melanomas and Spitz nevi
Rola Al Dhaybi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Growth rate as an independent prognostic factor in localized invasive cutaneous melanoma
E. Nagore et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Evaluation of self-assessed melanoma growth rate in a Mediterranean patient population
Vasiliki A. Nikolaou et al.
MELANOMA RESEARCH (2011)
Slow-growing melanoma: a dermoscopy follow-up study
G. Argenziano et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Growth rate as a prognostic factor in localized invasive cutaneous melanoma
A. Tejera-Vaquerizo et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
Nathalie Dhomen et al.
CANCER CELL (2009)
Computer versus human diagnosis of melanoma: evaluation of the feasibility of an automated diagnostic system in a prospective clinical trial
Stephan Dreiseitl et al.
MELANOMA RESEARCH (2009)
Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice
V. K. Goel et al.
ONCOGENE (2009)
Correlation of subjective self-reported melanoma growth rate with objective tumor proliferation markers
Wenyuan Liu et al.
ARCHIVES OF DERMATOLOGY (2008)
Rate of growth in melanomas - Characteristics and associations of rapidly growing melanomas
Wendy Liu et al.
ARCHIVES OF DERMATOLOGY (2006)
p16INK4A is a robust in vivo biomarker of cellular aging in human skin
Sigrun Ressler et al.
AGING CELL (2006)
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
V. C. Gray-Schopfer et al.
BRITISH JOURNAL OF CANCER (2006)
BRAFE600-associated senescence-like cell cycle arrest of human naevi
C Michaloglou et al.
NATURE (2005)
BRAF kinase gene V599E mutation in growing melanocytic lesions
R Loewe et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
BRAF mutation -: A frequent event in benign, atypical, and malignant melanocytic lesions of the skin
P Uribe et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2003)
Follow-up of melanocytic skin lesions with digital dermoscopy: Risks and benefits
H Kittler
ARCHIVES OF DERMATOLOGY (2002)
Share Paper
